CoChat

Effects of GLP1RAs on pregnancy rate and menstrual cyclicity in women with polycystic ovary syndrome: a meta-analysis and systematic review

Open access
Zhou, Lingling, Qu, Huanjia, Yang, Lu, Shou, Lan · 2023 · BMC Endocrine Disorders

The DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.

Abstract

Purpose: This study was aimed to assess the effectiveness of Glucagon-like peptide 1 receptor agonists on pregnancy rate, menses, anthropometric and hormonal parameters in PCOS patients. Methods: We conducted searches of the published literature in PubMed, EMBASE, Cochrane Library, Web of Science up to September 2022. Data from randomized controlled trials were obtained to assess the effects of GLP1RAs in PCOS women. Weighted mean difference, standardized mean difference, and risks ratio were employed for effect size estimation using a random-effects model. Results: A total of 840 patients with 469 individuals in GLP1RAs group and 371 individuals in control group from 11 RCTs were included. GLP1RAs usage was associated with an improvement in natural pregnancy rate (RR: 1.72, 95% CI 1.22 to 2.43, P = 0.002, I 2 = 0%) and menstrual regularity (SMD: 1.72, 95% CI 0.60 to 2.85, P < 0.001, I 2 = 95.6%). There were no statistically significant differences in total pregnancy rate, IVF pregnancy rate between two groups, but total PR elevated in a short time after GLP1RAs as shown in subgroup analysis. Randomization to GLP1RAs treatment was associated with great improvement in HOMA-IR, BMI, WC, SHBG and a slight reduction in TT compared to control group. A decrease in TBF was seen in European population. GLP1RAs monotherapy was not superior to metformin when it came to fT, DHEAS, FAI. Conclusions: Prescription of GLP1RAs improves natural pregnancy rate, menstrual cyclicity and insulin sensitivity, anthropometrics, hormonal indexes in PCOS women.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s12902-023-01500-5

Cites

57 of 57 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Flowchart showing the study selection process
Fig. 1 Flowchart showing the study selection processCC BY · PubMed Central
Fig. 2 Assessment of the risk of bias
Fig. 2 Assessment of the risk of biasCC BY · PubMed Central
Fig. 3 Effect on pregnancy rate: A natural pregnancy rate, B total pregnancy rate, C IVF pregnancy rate; 1 (follow-up more than 1 year), 2 (follow-up less than 1 year)
Fig. 3 Effect on pregnancy rate: A natural pregnancy rate, B total pregnancy rate, C IVF pregnancy rate; 1 (follow-up more than 1 year), 2 (follow-up less than 1 year)CC BY · PubMed Central
Fig. 4 Effect on menstrual cycles: 1 (GLP1RAs treatment duration for 12wk), 2 (GLP1RAs treatment duration for more than 12wk)
Fig. 4 Effect on menstrual cycles: 1 (GLP1RAs treatment duration for 12wk), 2 (GLP1RAs treatment duration for more than 12wk)CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 57 references

Research works printed but not linked: 1

  1. Vatankhah A, Izadi M, Rezvani ME, Esmailidehaj M. The effect of exenatide, a glucagon like peptide, on body weight, fasting blood glucose, lipid profile and Hba1c in rats with polycystic ovarian syndrome. J Reprod Infertil. 2016;17(2):201.

Cited by

See all 94

Metadata

Authors
Zhou, L., Qu, H., Yang, L., & Shou, L.
Affiliations
Hangzhou Normal University (CN)
Corresponding author
Shou, Lan
Venue
BMC Endocrine Disorders
Published
2023-11-08
Volume
23
Issue
1
Pages
245-245
ISSN
1472-6823 (ISSN-L)
OpenAlex
W4388496484
Cited by
66
References
57
Citations by year
2026: 35 · 2025: 22 · 2024: 9
FWCI
2.64
Type
journal article
Language
en
Open access
Licence
Locations
  • BMC Endocrine Disorders (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
Medical Science and Technology Project of Zhejiang Province (2023RC234)
Topics
  • Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Reproductive Health and Contraception
  • Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
Keywords
GLP-1 receptor agonists, polycystic ovary syndrome, pregnancy rate, menstrual cyclicity, insulin resistance, HOMA-IR, body mass index, sex hormone-binding globulin, total testosterone, free testosterone, dehydroepiandrosterone sulfate, free androgen index, metformin, in vitro fertilization pregnancy
MeSH terms
Female, Humans, Insulin Resistance, Metformin, Periodicity, Polycystic Ovary Syndrome, Pregnancy, Pregnancy Rate

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Effects of GLP1RAs on pregnancy rate and menstrual cyclicity in women with polycystic ovary syndrome: a meta-analysis and systematic review. https://app.cochat.ai/papers/10.1186/s12902-023-01500-5
The paper
Zhou, L., Qu, H., Yang, L., & Shou, L. (2023). Effects of GLP1RAs on pregnancy rate and menstrual cyclicity in women with polycystic ovary syndrome: a meta-analysis and systematic review. BMC Endocrine Disorders. https://doi.org/10.1186/s12902-023-01500-5

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.